Opcjonalna analityka produktu
Za zgodą użytkownika stosujemy ograniczoną analitykę chroniącą prywatność, aby zrozumieć, które ścieżki badawcze działają. Nie używamy trackerów reklamowych ani nagrywania sesji. Ten wybór można zmienić w Preferencjach. Przeczytaj Politykę prywatności.
Teradyne, Inc.'s published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $54.0B | |
|---|---|---|
| Revenue (ttm) | 5B | |
| Net income (ttm) | 1.4B | |
| EPS (ttm) | $8.71 | |
| Shares out | 156.3M | |
| P/E (trailing) | 36.1x | |
| P/E (forward) | 30.7x | |
| Dividend | $0.52 (0.17%) | |
| Volume | 4,332,888 | |
| Beta | 1.75 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $3.70B | $3.16B | $2.68B | $2.82B | $3.19B | -3.7% |
| Gross profit | $2.21B | $1.87B | $1.54B | $1.65B | $1.86B | -4.2% |
| Operating income | $1.20B | $831.9M | $501.1M | $593.8M | $650.1M | -14.2% |
| Net income | $1.01B | $715.5M | $448.8M | $542.4M | $554.0M | -14.0% |
| EPS (diluted) | $5.53 | $4.22 | $2.73 | $3.32 | $3.47 | -11.0% |
| EBITDA | $1.30B | $954.8M | $611.8M | $732.4M | $812.0M | -11.2% |
| R&D | $427.6M | $440.6M | $220.5M | $460.9M | $504.6M | +4.2% |
| SG&A | $547.6M | $558.1M | $577.3M | $617.0M | $648.9M | +4.3% |
Recent company headlines from major financial publishers.
Accelerating adoption of co-packaged optics, aggressive hyperscaler deployment of custom ARM server silicon, and robotics margin inflection drive compound earnings growth exceeding modeled baseline levels.
Test intensity remains elevated through FY2026 before stabilizing, supporting strong revenue expansion across FY2026 and FY2027. Operating margins expand in line with management guidance ranges and capital expenditures normalize relative to depreciation and revenue, supporting steady free cash flow expansion toward our Fair value target of $192.45.
| Ke ↓ / g → | 2.5% | 2.8% | 3.0% | 3.3% | 3.5% |
|---|---|---|---|---|---|
| 10.7% | $201 | $203 | $205 | $207 | $209 |
| 11.2% | $195 | $197 | $198 | $200 | $202 |
| 11.7% | $190 | $191 | $192 | $194 | $196 |
| 12.2% | $185 | $186 | $187 | $188 | $190 |
| 12.7% | $180 | $181 | $182 | $183 | $185 |
Upcoming earnings date and setup when available.
Rekomendacja, którą nosiło opublikowane w danym miesiącu wydanie analizy. Rekomendacja porównuje cenę z dnia analizy z wartością godziwą; nie jest zapisem tego, czy ocena się sprawdziła.
| Rok | sty | lut | mar | kwi | maj | cze | lip | sie | wrz | paź | lis | gru |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |